Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease (Q38094958)

28 August 2017

Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease (English)

1 reference

28 August 2017

5

1 reference

28 August 2017

2

Jonathan Carapetis

1 reference

28 August 2017

Bo Remenyi

1

1 reference

28 August 2017

Rosemary Wyber

series ordinal

3

1 reference

28 August 2017

Kathryn Taubert

series ordinal

4

1 reference

28 August 2017

World Heart Federation

series ordinal

6

1 reference

28 August 2017

language of work or name

English

0 references

publication date

2 April 2013

1 reference

Nature Reviews Cardiology

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

284-292

1 reference

28 August 2017

5

1 reference

Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease

28 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

The global burden of group A streptococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Death from rheumatic heart disease in rural Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

T. Duckett Jones Memorial Lecture. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Prevalence of rheumatic heart disease detected by echocardiographic screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Prevalence of rheumatic heart disease in children and young adults in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

High prevalence of rheumatic heart disease detected by echocardiography in school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Screening for rheumatic heart disease: current approaches and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Prophylaxis of recurrent rheumatic fever. Therapeutic-continuous oral penicillin vs monthly injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Reversibility of mitral regurgitation following rheumatic fever: clinical profile and echocardiographic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Clinical profile of acute rheumatic fever in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Global research priorities in rheumatic fever and rheumatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

21 January 2018

Rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rheumatic fever: neglected again

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rheumatic heart disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Donor funding priorities for communicable disease control in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Prevention of rheumatic fever in Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

How absolute is zero? An evaluation of historical and current definitions of malaria elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Vaccination against rheumatic heart disease: a review of current research strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rheumatic fever recurrence prevention: a nurse-led programme of 28-day penicillin in an area of high endemnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

25 years of the WHO essential medicines lists: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1,200,000 units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Management of oral anticoagulation in a population of children with cardiac disease using a computerised system to support decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Pregnancy in women with heart disease in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

High prevalence of subclinical rheumatic heart disease in pregnant women in a developing country: an echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Global aspects of cardiothoracic surgery with focus on developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

10-year educational programme aimed at rheumatic fever in two French Caribbean islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Effectiveness of comprehensive-care programs in preventing rheumatic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Rheumatic heart disease: the tip of the iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Benzathine penicillin G: a documentably important antibiotic in need of a tune-up?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

The case for a global rare-diseases registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.34

Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart A

31 March 2020

1 reference

12 December 2020

Cardiac disease in pregnancy

1 reference

12 December 2020

Rheumatic Fever Programme in Samoa.

1 reference

12 December 2020

The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project

1 reference

12 December 2020

A community-based rheumatic fever/rheumatic heart disease cohort: twelve-year experience.

1 reference

12 December 2020

Surgery for rheumatic mitral regurgitation in patients below twenty years of age. An analysis of failures

1 reference

12 December 2020

Group A streptococcal vaccines: paving a path for accelerated development

1 reference

12 December 2020

Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis

1 reference

12 December 2020

Childhood rheumatic heart disease in Nigeria

1 reference

12 December 2020

Epidemiological analysis of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand

1 reference

12 December 2020

Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever--a systematic review

1 reference

12 December 2020

The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa.

1 reference

12 December 2020

Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002).

1 reference

12 December 2020

Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme.

1 reference

12 December 2020

High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2013.34

1 reference

28 August 2017

1 reference